Cybersecurity firm BrandShield took down over 250 websites that sold fake versions of weight-loss and diabetes drugs in the GLP-1 class. In an interview with Reuters, the company said that over 90% of drugs intended to treat metabolic conditions, over 90% were related to GLP-1 medicines.